Loading...
Surgery Partners, Inc.
SGRY•NASDAQ
Healthcare
Medical - Care Facilities
$21.26
$0.25(1.19%)
Surgery Partners, Inc. (SGRY) Financial Performance & Income Statement Overview
Review Surgery Partners, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.52%
↑ 13.52%
Operating Income Growth
6.34%
↑ 6.34%
Net Income Growth
-1312.61%
↓ 1312.61%
Operating Cash Flow Growth
2.14%
↑ 2.14%
Operating Margin
10.55%
↑ 10.55%
Gross Margin
22.64%
↑ 22.64%
Net Profit Margin
-6.10%
↓ 6.10%
ROE
-10.48%
↓ 10.48%
ROIC
4.54%
↑ 4.54%
Surgery Partners, Inc. (SGRY) Income Statement & Financial Overview
Review Surgery Partners, Inc.'s (SGRY) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $864.40M | $770.40M | $762.10M | $717.40M |
Cost of Revenue | $630.80M | $592.90M | $582.90M | $595.80M |
Gross Profit | $233.60M | $177.50M | $179.20M | $121.60M |
Gross Profit Ratio | $0.27 | $0.23 | $0.24 | $0.17 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $36.00M | $120.20M | $40.30M | $33.20M |
Operating Expenses | $127.10M | $116.60M | $40.30M | $33.20M |
Total Costs & Expenses | $757.90M | $709.50M | $677.30M | $629.00M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $52.90M | $50.00M | $51.50M | $47.30M |
Depreciation & Amortization | $33.90M | $50.20M | $34.80M | $33.70M |
EBITDA | $173.70M | $111.10M | $119.60M | $109.70M |
EBITDA Ratio | $0.20 | $0.14 | $0.16 | $0.15 |
Operating Income | $127.10M | $60.90M | $84.80M | $88.40M |
Operating Income Ratio | $0.15 | $0.08 | $0.11 | $0.12 |
Other Income/Expenses (Net) | -$52.90M | -$50.00M | -$51.50M | -$47.30M |
Income Before Tax | $74.20M | $10.90M | $33.30M | $28.70M |
Income Before Tax Ratio | $0.09 | $0.01 | $0.04 | $0.04 |
Income Tax Expense | $120.80M | $4.50M | $4.90M | $4.40M |
Net Income | -$108.50M | -$31.70M | -$15.50M | -$12.40M |
Net Income Ratio | -$0.13 | -$0.04 | -$0.02 | -$0.02 |
EPS | -$0.86 | -$0.25 | -$0.12 | -$0.10 |
Diluted EPS | -$0.86 | -$0.25 | -$0.12 | -$0.10 |
Weighted Avg Shares Outstanding | $126.21M | $126.17M | $126.13M | $125.97M |
Weighted Avg Shares Outstanding (Diluted) | $126.21M | $126.17M | $126.13M | $125.97M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan